High anaphylaxis rates following vaccination with the Pfizer BNT162b2 mRNA vaccine against COVID-19 in Japanese healthcare workers, a secondary analysis of initial post-approval safety data
Hypereosinophilic Syndrome Following the BNT162b2 (BioNTech Pfizer) Vaccine Successfully Treated with Mepolizumab, A Case Report and Review of the Literature